These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 24371243)
41. Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus. Sader HS; Fritsche TR; Jones RN Antimicrob Agents Chemother; 2008 Mar; 52(3):1153-5. PubMed ID: 18180353 [TBL] [Abstract][Full Text] [Related]
42. First report of infection with community-acquired methicillin-resistant Staphylococcus aureus in South America. Ribeiro A; Dias C; Silva-Carvalho MC; Berquó L; Ferreira FA; Santos RN; Ferreira-Carvalho BT; Figueiredo AM J Clin Microbiol; 2005 Apr; 43(4):1985-8. PubMed ID: 15815039 [TBL] [Abstract][Full Text] [Related]
43. Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers. Mendes RE; Sader HS; Deshpande L; Jones RN Diagn Microbiol Infect Dis; 2008 Apr; 60(4):433-6. PubMed ID: 18068326 [TBL] [Abstract][Full Text] [Related]
44. Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea. Nam HM; Lee AL; Jung SC; Kim MN; Jang GC; Wee SH; Lim SK Foodborne Pathog Dis; 2011 Feb; 8(2):231-8. PubMed ID: 21034263 [TBL] [Abstract][Full Text] [Related]
46. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920 [TBL] [Abstract][Full Text] [Related]
47. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Oliveira GA; Dell'Aquila AM; Masiero RL; Levy CE; Gomes MS; Cui L; Hiramatsu K; Mamizuka EM Infect Control Hosp Epidemiol; 2001 Jul; 22(7):443-8. PubMed ID: 11583214 [TBL] [Abstract][Full Text] [Related]
48. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Kourbatova EV; Halvosa JS; King MD; Ray SM; White N; Blumberg HM Am J Infect Control; 2005 Sep; 33(7):385-91. PubMed ID: 16153484 [TBL] [Abstract][Full Text] [Related]
49. Molecular epidemiology of community-associated antimicrobial-resistant Staphylococcus aureus in Seoul, Korea (2003): pervasiveness of multidrug-resistant SCCmec type II methicillin-resistant S. aureus. Jeong HY; Lee JE; Choi BK; Seo KW; Park SH; Kim YL; Baek KM; Lee K; Rhee DK Microb Drug Resist; 2007; 13(3):178-85. PubMed ID: 17949304 [TBL] [Abstract][Full Text] [Related]
50. Multidrug and vancomycin resistance among clinical isolates of Olufunmiso O; Tolulope I; Roger C Afr Health Sci; 2017 Sep; 17(3):797-807. PubMed ID: 29085408 [TBL] [Abstract][Full Text] [Related]
51. Identification of the first vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolate from a hospital in Portugal. Gardete S; Aires-De-Sousa M; Faustino A; Ludovice AM; de Lencastre H Microb Drug Resist; 2008 Mar; 14(1):1-6. PubMed ID: 18346009 [TBL] [Abstract][Full Text] [Related]
52. First Report on Vancomycin-Resistant Staphylococcus aureus in Bovine and Caprine Milk. Bhattacharyya D; Banerjee J; Bandyopadhyay S; Mondal B; Nanda PK; Samanta I; Mahanti A; Das AK; Das G; Dandapat P; Bandyopadhyay S Microb Drug Resist; 2016 Dec; 22(8):675-681. PubMed ID: 26990514 [TBL] [Abstract][Full Text] [Related]
53. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512 [TBL] [Abstract][Full Text] [Related]
54. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. Sieradzki K; Roberts RB; Haber SW; Tomasz A N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472 [No Abstract] [Full Text] [Related]
55. Effect of vancomycin on the cytoplasmic membrane fatty acid profile of vancomycin-resistant and -susceptible isolates of Staphylococcus aureus. Mirani ZA; Jamil N J Infect Chemother; 2013 Feb; 19(1):24-33. PubMed ID: 22821354 [TBL] [Abstract][Full Text] [Related]
56. Genomic organization of a vancomycin-resistant Staphylococcus aureus. Mirani ZA; Jamil N J Coll Physicians Surg Pak; 2013 Feb; 23(2):107-11. PubMed ID: 23374512 [TBL] [Abstract][Full Text] [Related]
57. High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China. Shen P; Zhou K; Wang Y; Song J; Liu Y; Zhou Y; Xiao Y J Antimicrob Chemother; 2019 Sep; 74(9):2537-2543. PubMed ID: 31203362 [TBL] [Abstract][Full Text] [Related]
58. Antimicrobial Resistance Profile and Molecular Characteristics of Staphylococcus aureus Isolates from Hospitalized Adults in Three Regions of Vietnam. Thai Son N; Thu Huong VT; Kim Lien VT; Quynh Nga DT; Hai Au TT; Thu Hang PT; Nguyet Minh HT; Binh TQ Jpn J Infect Dis; 2020 May; 73(3):193-200. PubMed ID: 31875603 [TBL] [Abstract][Full Text] [Related]